What Is Librela and What Does It Treat?
Librela is a prescription medication used to control the pain of osteoarthritis in dogs. Its active ingredient is bedinvetmab, and it represents a genuinely new approach to canine arthritis pain. Librela is FDA-approved (and approved by European regulators) specifically for this use.
Librela is not a traditional drug at all — it is a monoclonal antibody. Bedinvetmab is a canine monoclonal antibody engineered to target a protein called nerve growth factor (NGF). In arthritic joints, NGF is produced in elevated amounts and plays a central role in transmitting the pain signal to the brain and in driving inflammation. Librela works by binding to NGF and neutralising it, which reduces the pain signal at its source.
Because it is an antibody rather than a small-molecule drug, Librela is not processed by the liver or kidneys the way conventional medications are — it is broken down and recycled like the body’s own antibodies. This is part of what makes it an appealing option, particularly for older dogs or dogs where traditional anti-inflammatory drugs are difficult to use.
The defining feature of Librela for owners is its convenience: it is a single subcutaneous injection given once a month by a veterinarian. Between injections, there are no daily tablets to remember.
Two honest points are important. First, Librela controls pain but does not treat, slow or reverse the arthritis itself — the underlying joint disease continues. Second, it works best as part of a complete arthritis plan. Use the calculator above to understand the weight-band dosing, but Librela must be prescribed and administered by a veterinarian. For more, see PuppaDogs’ guide to Librela for dogs.
How the Librela Dosage Calculator Works
Unlike most medications, Librela is not dosed by an exact per-kilogram amount. Instead, it uses fixed weight bands — much like a vaccine — with pre-measured vials of different strengths. The calculator:
- Places your dog in the correct weight band.
- Shows the vial strength(s) to be used and the total monthly dose.
- Confirms the once-monthly subcutaneous route.
- Flags the conditions in which Librela must not be used.
Enter your dog’s weight, tick any health considerations, then press Find Weight Band.
How Librela Doses Are Calculated for Dogs
The Minimum Dose and Monthly Schedule
The minimum target dose of Librela is 0.5 mg/kg of body weight, given by subcutaneous injection once a month. To deliver this conveniently, Librela is supplied in five vial strengths — 5, 10, 15, 20 and 30 mg — and dogs are assigned to a weight band, each band receiving a specific vial or combination of vials.
The Weight-Band Dosing Table
| Dog body weight | Librela dose | Vial(s) used |
|---|---|---|
| Under 5 kg (under 11 lb) | 0.5 mg/kg | drawn by volume from the 5 mg/mL vial |
| 5–10 kg (11–22 lb) | 5 mg | one 5 mg vial |
| 10.1–20 kg (22–44 lb) | 10 mg | one 10 mg vial |
| 20.1–30 kg (44–66 lb) | 15 mg | one 15 mg vial |
| 30.1–40 kg (66–88 lb) | 20 mg | one 20 mg vial |
| 40.1–60 kg (88–132 lb) | 30 mg | one 30 mg vial |
| 60.1–80 kg (132–176 lb) | 40 mg | two 20 mg vials |
| 80.1–100 kg (176–220 lb) | 50 mg | one 20 mg + one 30 mg vial |
| 100.1–120 kg (220–265 lb) | 60 mg | two 30 mg vials |
Each band is designed so the dog receives at least the minimum 0.5 mg/kg. Very small dogs (under 5 kg) are dosed precisely by volume — 0.1 mL per kg drawn from the 5 mg/mL vial.
How Librela Is Given to Your Dog
- Route: Librela is given as a subcutaneous injection (under the skin) by your veterinarian.
- Frequency: Once a month — every 28–30 days.
- It is not a home medication: the injection is administered at the veterinary clinic.
- Discuss before each injection: the manufacturer specifically recommends that, before *every* monthly injection, you and your vet review how your dog is doing, any new health changes, and whether Librela should continue.
What to Expect From Treatment
Librela does not work instantly. It may take two monthly injections — given a month apart — before you see the full reduction in your dog’s arthritis pain. Many owners then notice their dog moving more comfortably, being more willing to walk, climb stairs or play.
One practical point the manufacturer highlights: if a dog has been very inactive because of arthritis pain, it may suddenly want to do much more once the pain is controlled. To avoid injury, discuss a gradual return-to-activity plan with your veterinarian.
Side Effects and Safety Warnings
Librela is generally well tolerated, and in the original field studies the reported side effects were broadly similar to placebo, with some increase in things such as urinary tract infections, skin and injection-site reactions, and, in the European study, increased blood urea nitrogen (BUN).
However, post-approval reporting has highlighted neurological side effects, and every owner should be aware of them. Contact your veterinarian if your dog shows:
- Balance problems, trouble walking, standing or weakness
- Seizures, paralysis or loss of coordination
- Increased drinking or urination, or loss of bladder control
- Vomiting or diarrhoea, lethargy or loss of appetite
Serious adverse events, including ones resulting in death or euthanasia, have been reported. This does not mean Librela is unsafe for most dogs — but it does mean you should monitor your dog, report changes promptly, and review the treatment with your vet before each injection.
When Librela Must Not Be Used
Librela should not be used in dogs that:
- Are younger than 12 months of age — NGF is important in the developing nervous system
- Are used for breeding, or are pregnant or nursing — the antibody can cross the placenta and enter milk
- Have a known hypersensitivity to bedinvetmab
It should be used with caution and full veterinary discussion in dogs with heart disease, neurological signs, and in dogs on long-term NSAIDs (the safety of that combination is not fully established).
How Librela Fits Into Arthritis Care
Librela controls pain, but a complete arthritis plan does more. The most effective management is multimodal and may also include:
- Weight management — keeping your dog lean dramatically reduces joint load
- Controlled, appropriate exercise and physiotherapy
- Joint supplements, omega-3 fatty acids, and other supportive treatments such as Adequan
- Home adjustments — ramps, traction on slippery floors, supportive bedding
Your veterinarian may also discuss other pain medications, such as Galliprant, depending on your dog’s needs.
Conclusion
Librela (bedinvetmab) is a modern, once-monthly injectable treatment that controls the pain of canine osteoarthritis by neutralising nerve growth factor. It is dosed not by an exact per-kilogram figure but by fixed weight bands, delivering a minimum of 0.5 mg/kg once a month. The calculator above shows which band and vial strength apply to your dog. Because it is a prescription injectable given by a veterinarian, and because neurological side effects have been reported since its approval, the most important habit is simple: monitor your dog, report any changes, and review the treatment with your vet before every monthly injection — using Librela as one part of a complete, vet-guided arthritis plan.
Frequently Asked Questions
How is Librela dosed for dogs?
Librela (bedinvetmab) is dosed by fixed weight bands rather than an exact per-kilogram amount, with a minimum target dose of 0.5 mg/kg given by subcutaneous injection once a month. Each weight band receives a specific vial strength – for example, a 10.1-20 kg dog receives a 10 mg vial, and a 20.1-30 kg dog receives a 15 mg vial.
How often is Librela given to dogs?
Librela is given as a single subcutaneous injection once a month – every 28 to 30 days – by a veterinarian. There are no daily tablets between injections. The manufacturer recommends that you and your vet review your dog’s response and health before each monthly injection.
How long does Librela take to work?
Librela does not work instantly. It may take two monthly injections, given a month apart, before you see the full reduction in your dog’s osteoarthritis pain. After that, many owners notice their dog moving more comfortably and being more willing to walk, climb stairs and play.
What are the side effects of Librela in dogs?
In field studies, side effects were broadly similar to placebo, with some increase in urinary tract infections, skin and injection-site reactions and, in one study, raised blood urea nitrogen. Since approval, neurological side effects – balance problems, trouble walking, weakness, seizures and paralysis – have been reported. Report any such changes to your vet promptly.
Which dogs should not be given Librela?
Librela must not be used in dogs younger than 12 months of age, or in dogs that are used for breeding, pregnant or nursing, or that have a known hypersensitivity to bedinvetmab. It should be used with caution and full veterinary discussion in dogs with heart disease, neurological signs, or on long-term NSAID treatment.
Does Librela cure arthritis in dogs?
No. Librela controls the pain associated with osteoarthritis, but it does not treat, slow or reverse the underlying joint disease. It works best as part of a complete, multimodal arthritis plan that also includes weight management, appropriate exercise, joint support and home adjustments, all guided by your veterinarian.
Related PuppaDogs Calculators
Continue building your dog’s personalised care plan with these related PuppaDogs calculators:
- Dog Pregnancy / Whelping Due-Date Calculator
- Puppy Weight Predictor (Adult Weight Calculator)
- Heatstroke Risk Calculator for Dogs
- Bloat (GDV) Risk Calculator for Dogs
- Dog Life Expectancy Calculator (Breed, Body Condition, Lifestyle)
- Spay/Neuter Timing Calculator for Dogs (Breed-Specific)
References & Further Reading
The dosing ranges and safety information on this page are drawn from the following veterinary references. Always defer to your own veterinarian and the manufacturer’s label for your specific product.
- Librela (bedinvetmab injection) – FDA-approved package insert and dosing table, Zoetis Inc. (NADA 141-562).
- U.S. FDA Center for Veterinary Medicine. Librela approval and prescribing information. fda.gov.
- European Medicines Agency. Librela (bedinvetmab) – summary of product characteristics. ema.europa.eu.
- Merck Veterinary Manual. Osteoarthritis in dogs – anti-NGF monoclonal antibody therapy. merckvetmanual.com.
- PuppaDogs. Librela for Dogs: Effective Osteoarthritis Relief. puppadogs.com.
